Shareholder alert: class action lawsuit filed on behalf of revance therapeutics, inc. (rvnc) investors – holzer & holzer, llc encourages investors with significant losses to contact the firm

Atlanta, jan. 06, 2025 (globe newswire) -- a shareholder class action lawsuit has been filed against revance therapeutics, inc. (“revance” or the “company”) (nasdaq: rvnc). the lawsuit alleges that defendants made materially false and/or misleading statements, and/or failed to disclose material adverse facts about revance's business, operations, and prospects, including allegations that: (i) revance was in material breach of its distribution agreement with teoxane sa; (ii) the foregoing subjected revance to an increased risk of litigation, as well as monetary and reputational harm; and (iii) all the foregoing increased the risk that crown laboratories, inc.'s tender offer to acquire all outstanding shares of the company's common stock would be delayed and/or amended.
RVNC Ratings Summary
RVNC Quant Ranking